TherapeuticsMD Inc (TXMD) — Strategic Asset Allocation Index
TherapeuticsMD Inc (TXMD) has a Strategic Asset Allocation Index of 0.2% as of March 2023. Strategic assets (PP&E of $58.00K plus long-term investments of $-) total $58.00K, measured against net assets of $32.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
TherapeuticsMD Inc Strategic Asset Allocation Index (2013–2019)
This chart shows how TherapeuticsMD Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2013 to 2019. As of March 2023, the index stands at 0.2%, representing strategic assets of $58.00K against net assets of $32.02 Million USD. Explore TXMD cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for TherapeuticsMD Inc (2013–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for TherapeuticsMD Inc from 2013 to 2019, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see TherapeuticsMD Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 137.1% | $12.62 Million | $12.62 Million | $- | $9.20 Million | ▲ +136.6 pp |
| 2018 | 0.5% | $472.68K | $472.68K | $- | $97.52 Million | ▲ +0.1 pp |
| 2017 | 0.3% | $437.06K | $437.06K | $- | $129.91 Million | ▼ -0.1 pp |
| 2016 | 0.4% | $516.84K | $516.84K | $- | $127.49 Million | ▲ +0.1 pp |
| 2015 | 0.3% | $198.59K | $198.59K | $- | $63.06 Million | ▲ +0.2 pp |
| 2014 | 0.1% | $63.29K | $63.29K | $- | $48.39 Million | ▲ +0.0 pp |
| 2013 | 0.1% | $61.32K | $61.32K | $- | $54.70 Million | — |